Level Biotechnology Inc. was established in December 1989. Formerly known as Advanced Technology, in 1989 it changed its name to A Level Biotechnology. Public offering was issued in June 2001. The main business is divided into biomedical products and pre-clinical trials. Its revenue sources from consuming material fostering, antibody reagents, and instruments and equipments. The domestic-based sales channels are the major research institutions. And its customers are Corning organisms, Academia Sinica, Jin-order technology, National Taiwan University hospitals and etc. Sources of technology: A. This Company opposes the chimerical transgenic technology transferred from Academia Sinica. B. It also has protein-protein interaction technology trough technology transfer from National Institutes of Health study of. C. The company takes exclusively of transgenic mice market in Taiwan. D. The company cooperates with Animal Center of National Taiwan University on the raw materials in mice.
Headquarters
No.80,Lane 169, Kang Ning St., Hsi-Chih
New Taipei City; New Taipei City;
Contact Details: Purchase the Level Biotechnology Inc. report to view the information.
Website: http://www.level.com.tw
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service